All Stories

  1. Species Distribution and Comparison between EUCAST and Gradient Concentration Strips Methods for Antifungal Susceptibility Testing of 112 Aspergillus Section Nigri Isolates
  2. Autochthonous liver cystic hydatid: Past or actual French shepherd's disease?
  3. Repurposing of Ribavirin as an Adjunct Therapy against Invasive Candida Strains in an In Vitro Study
  4. Mycobacterium ulcerans mycolactones-fungi crosstalking
  5. Microbiome and the immune system: From a healthy steady-state to allergy associated disruption
  6. Malaria, tuberculosis and HIV: what's new? Contribution of the Institut Hospitalo-Universitaire Méditerranée Infection in updated data
  7. Mansonellosis, the most neglected human filariasis
  8. Current antifungal treatment of fusariosis
  9. Nucleotide Sequence Database Comparison for Routine Dermatophyte Identification by Internal Transcribed Spacer 2 Genetic Region DNA Barcoding
  10. Species Identification and In Vitro Antifungal Susceptibility of Aspergillus terreus Species Complex Clinical Isolates from a French Multicenter Study
  11. Successful Treatment of Pulmonary and Cerebral Toxoplasmosis Associated with Pneumocystis Pneumonia in an HIV Patient
  12. Culturomics and Amplicon-based Metagenomic Approaches for the Study of Fungal Population in Human Gut Microbiota
  13. Une pseudo-tumeur cutanée chez un patient transplanté rénal
  14. Virtual special section ‘new challenges in antifungal therapy’
  15. A Case of Fungus Ball-Type Maxillary Sinusitis Due to Penicillium Roqueforti
  16. Which environmental conditions are suitable for the pathogenic yeast Cryptococcus neoformans
  17. Multivariate Analysis As a Support for Diagnostic Flowcharts in Allergic Bronchopulmonary Aspergillosis: A Proof-of-Concept Study
  18. Many More Microbes in Humans: Enlarging the Microbiome Repertoire
  19. Medical Entomology: A Reemerging Field of Research to Better Understand Vector-Borne Infectious Diseases
  20. Validation of a New Web Application for Identification of Fungi by Use of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry
  21. Aspergillus fumigatusin cystic fibrosis: An update on immune interactions and molecular diagnostics in allergic bronchopulmonary aspergillosis
  22. Anthropogenic impact on environmental filamentous fungi communities along the Mediterranean littoral
  23. Decision criteria for MALDI-TOF MS-based identification of filamentous fungi using commercial and in-house reference databases
  24. Maxillary sinus volume: new physiopathological data in fungal ball genesis? A retrospective study
  25. Arthrocladium fulminans Arthritis and Osteomyelitis
  26. Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin
  27. Opportunistic fungal pathogen Candida glabrata circulates between humans and yellow-legged gulls
  28. Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species
  29. MALDI-TOF-Based Dermatophyte Identification
  30. Performance of MALDI-TOF MS platforms for fungal identification
  31. Previously unknown species of Aspergillus
  32. Genetic diversity of Plasmodium falciparum in human malaria cases in Mali
  33. Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin
  34. Environmental distribution ofCryptococcus neoformansandC. gattiiaround the Mediterranean basin
  35. Dermatophytosis among Schoolchildren in Three Eco-climatic Zones of Mali
  36. Aspergillus tubingensis: a major filamentous fungus found in the airways of patients with lung disease
  37. Routine identification and mixed species detection in 6,192 clinical yeast isolates
  38. Schizophyllum commune: an emergent or misdiagnosed fungal pathogen in rhinology?
  39. Microsatellite Typing of Aspergillus flavus Strains in a Tunisian Onco-hematology Unit
  40. Disseminated histoplasmosis partially mimicking a dermatomyositis in a patient with rheumatoid arthritis
  41. Molecular identification of Mucorales in human tissues: contribution of PCR electrospray-ionization mass spectrometry
  42. Genotype combinations of two IL4 polymorphisms influencing IL-4 plasma levels are associated with different risks of severe malaria in the Malian population
  43. MALDI-TOF typing highlights geographical and fluconazole resistance clusters in Candida glabrata
  44. International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database—the quality controlled standard tool for routine identification of human and animal pathogenic fungi
  45. Cochliobolus hawaiiensis Sinusitis, a Tropical Disease? A Case Report and Review of the Literature
  46. Hospital environment fungal contamination and aspergillosis risk in acute leukaemia patients in Sousse (Tunisia)
  47. A non-polyenic antifungal produced by a Streptomyces   yatensis strain isolated from Mellah Lake in El Kala, North-East of Algeria
  48. Distribution of Keratinophilic Fungi in Soil Across Tunisia: A Descriptive Study and Review of the Literature
  49. Comparison of MALDI-TOF mass spectra with microsatellite length polymorphisms inCandida albicans
  50. A Double-Blind Randomized Placebo-Controlled Clinical Trial of Squalamine Ointment for tinea capitis Treatment
  51. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: revolutionizing clinical laboratory diagnosis of mould infections
  52. Evaluation of the Aspergillus Western Blot IgG Kit for Diagnosis of Chronic Aspergillosis
  53. High dermatophyte contamination levels in hairdressing salons of a West African suburban community
  54. Posttraumatic Mucormycosis
  55. Identification of filamentous fungi isolates by MALDI-TOF mass spectrometry: clinical evaluation of an extended reference spectra library
  56. Trailing or paradoxical growth of Aspergillus flavus exposed to caspofungin is independent of genotype
  57. Changes in Genotype and Fluconazole Susceptibility of Isolates from Patients with Candida glabrata in Tunisia
  58. Méningite à Candida albicans chez l’adulte, apport des nouveaux moyens diagnostiques
  59. Fast and Accurate Identification of Dermatophytes by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry: Validation in the Clinical Laboratory
  60. Preliminary Study of the Fungal Ecology at the Haematology and Medical-Oncology Ward in Bamako, Mali
  61. Characteristics of Invasive Aspergillosis in Neutropenic Haematology Patients (Sousse, Tunisia)
  62. In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia
  63. Comparison of real-time PCR with conventional methods to detect dermatophytes in samples from patients with suspected dermatophytosis
  64. A MALDI-TOF MS procedure for clinical dermatophyte species identification in the routine laboratory
  65. Microsatellite typing of Aspergillus flavus in patients with various clinical presentations of aspergillosis
  66. Cutaneous hyalohyphomycosis caused by Purpureocillium lilacinum in an immunocompetent patient: case report and review
  67. MALDI‐TOF mass spectrometry identification of filamentous fungi in the clinical laboratory
  68. Evaluation of four pretreatment procedures for MALDI-TOF MS yeast identification in the routine clinical laboratory
  69. In vitro activity of aminosterols against dermatophytes
  70. Saccharomyces cerevisiae boulardii transient fungemia after intravenous self-inoculation
  71. Assessment of various parameters to improve MALDI-TOF MS reference spectra libraries constructed for the routine identification of filamentous fungi
  72. Interactions between copy number and expression level of genes involved in fluconazole resistance in Candida glabrata
  73. Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection
  74. A strategy based on galactomannan antigen detection and PCR for invasive pulmonary aspergillosis following influenza A (H1N1) pneumonia
  75. Simple and Highly Discriminatory VNTR-Based Multiplex PCR for Tracing Sources of Aspergillus flavus Isolates
  76. Microsatellite typing of Aspergillus flavus from clinical and environmental avian isolates
  77. Genetic structure of Aspergillus flavus populations in human and avian isolates
  78. Scedosporium apiospermum catheter-related soft-tissue infection: a case report and review of the literature
  79. The efficacy of voriconazole in 24 ocular Fusarium infections
  80. Interlaboratory Reproducibility of Etest Amphotericin B and Caspofungin Yeast Susceptibility Testing and Comparison with the CLSI Method
  81. Late post-operative Aspergillus flavus endocarditis: Demonstration of a six years incubation period using microsatellite typing
  82. Mould Routine Identification in the Clinical Laboratory by Matrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass Spectrometry
  83. Imported Acquired Immunodeficiency Syndrome–Related Histoplasmosis in Metropolitan France: A Comparison of Pre–Highly Active Anti-Retroviral Therapy and Highly Active Anti-Retroviral Therapy Eras
  84. Mefloquine for Uncomplicated Plasmodium falciparum Malaria in Children
  85. Optimization of Toxoplasma gondii DNA extraction from amniotic fluid using NucliSENS easyMAG and comparison with QIAamp DNA minikit
  86. In vitro activity of aminosterols against yeasts involved in blood stream infections
  87. Pseudallescheria/Scedosporium complex species identification by matrix-assisted laser desorption ionization time-of-flight mass spectrometry
  88. Immune reconstitution inflammatory syndrome mimicking relapsing cryptococcal meningitis in a renal transplant recipient
  89. Comparison of PCR-ELISA and Real-Time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies
  90. Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi
  91. Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center study
  92. International Retrospective Analysis of 73 Cases of Invasive Fusariosis Treated with Voriconazole
  93. Risk Factors for Aspergillus Colonization and Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis
  94. Microsatellite Typing To Trace Aspergillus flavus Infections in a Hematology Unit
  95. In vitro antifungal activity of aminosterols against moulds isolated from cystic fibrosis patients
  96. Trailing or Paradoxical Growth of Candida albicans When Exposed to Caspofungin Is Not Associated with Microsatellite Genotypes
  97. Frequency of Drug Resistance Gene Amplification in ClinicalLeishmaniaStrains
  98. Un abcés pulmonaire qui ne guérit sous antibiotiques
  99. Intradural dirofilariasis mimicking a Langerhans cell histiocytosis tumor
  100. Evaluation of nested and real-time PCR assays in the diagnosis of candidaemia
  101. Modelling malaria incidence with environmental dependency in a locality of Sudanese savannah area, Mali
  102. Isolement d’ Exophiala dermatitidis dans des prélèvements d’origine pulmonaire : à propos de six patients
  103. Scedosporium prolificans : an emerging pathogen in France?
  104. Isolation of Trichoderma atroviride from a liver transplant
  105. Neurocysticercose cérébrale au stade de dégénérescence : diagnostic différentiel des métastases cérébrales
  106. H-08 Champignons isolés d’hémocultures au CHU de Marseille
  107. Successful treatment of a giant isolated cerebral mucormycotic (zygomycotic) abscess using endoscopic debridement: case report and therapeutic considerations
  108. Life-Threatening Malaria in African Children a Prospective Study in a Mesoendemic Urban Setting
  109. Contribution of the (1->3)- -D-Glucan Assay for Diagnosis of Invasive Fungal Infections
  110. Platelia Aspergillus assay for diagnosis of disseminated histoplasmosis
  111. Mefloquine versus 3-day oral quinine–clindamycin in uncomplicated imported falciparum malaria
  112. Détection de clusters spatiaux sans point source prédéfini: utilisation de cinq méthodes et comparaison de leurs résultats
  113. Severe Toxoplasma gondii I/III Recombinant-Genotype Encephalitis in a Human Immunodeficiency Virus Patient
  114. Space-time clustering of childhood malaria at the household level: a dynamic cohort in a Mali village
  115. Facteurs de risque d'événements aspergillaires chez l'enfant atteint de mucoviscidose
  116. Alleles 308A and 238A in the Tumor Necrosis Factor Alpha Gene Promoter Do Not Increase the Risk of Severe Malaria in Children with Plasmodium falciparum Infection in Mali
  117. Timely Diagnosis of Disseminated Toxoplasmosis by Sputum Examination
  118. Oral Ivermectin in the Treatment of Body Lice
  119. Treatment of imported malaria in adults: a multicentre study in France
  120. Oblique decision trees for spatial pattern detection: optimal algorithm and application to malaria risk
  121. Familial Aggregation of Cerebral Malaria and Severe Malarial Anemia
  122. In vitro activity of azithromycin and dirithromycin against axenic Entamoeba histolytica
  123. Risk factors for severe malaria in Bamako, Mali: a matched case-control study
  124. Three-Day Quinine-Clindamycin Treatment of Uncomplicated Falciparum Malaria Imported from the Tropics
  125. Imported cutaneous gnathostomiasis: report of five cases
  126. Le traitement des prostatites
  127. Follow-up of Ascaris lumbricoides and Trichuris trichiura infections in children living in a community treated with ivermectin at 3-monthly intervals
  128. The Treatment of Babesiosis
  129. Controlled Trial of 3-Day Quinine-Clindamycin Treatment versus 7-Day Quinine Treatment for Adult Travelers with Uncomplicated Falciparum Malaria Imported from the Tropics
  130. Trichinella pseudospiralis Outbreak in France
  131. Genetic epidemiology of host predisposition microfilaraemia in human loiasis
  132. Impact of repeated large scale ivermectin treatments on the transmission of Loa loa
  133. La maladie de Kikuchi-Fujimoto: une adénite particulière
  134. Decreased prevalence and intensity of Loa loa infection in a community treated with ivermectin every three months for two years